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Primed Neutrophil Apoptosis and Clearance by
Macrophages
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Dwoma Adu,* and Caroline O. S. Savage*
From the Department of Renal Immunobiology,* MRC Centre for
Immune Regulation, The Medical School, University of
Birmingham, Edgbaston, Birmingham, England; and the Centre
for Inflammation Research,† University of Edinburgh,
Department of Clinical and Surgical Sciences, Internal Medicine,
Royal Infirmary, Edinburgh, Scotland
This study assessed whether anti-neutrophil cytoplas-
mic antibodies (ANCAs) interfere with the safe deletion
of neutrophils by apoptosis and phagocytic clearance.
Tumor necrosis factor (TNF)-primed neutrophils were
incubated with normal IgG (N IgG) or ANCA IgG for up
to 36 hours. Compared with N IgG, ANCAs accelerated
constitutive apoptosis of TNF-a primed neutrophils,
as assessed by morphology and confirmed by DNA
laddering pattern on gel electrophoresis, and accel-
erated progression to secondary necrosis. The accel-
erated apoptosis induced by ANCA was dependent on
reactive oxygen species generation, as primed neu-
trophils from patients with chronic granulomatous
disease failed to show an effect of ANCAs on apopto-
sis. However, there was no change in the rate at
which neutrophils exhibited annexin V binding, in-
dicating that externalization of phosphatidylserine
was not accelerated by ANCAs. Furthermore, when
ANCA-treated primed neutrophils were interacted
with human or murine peritoneal macrophages after
12 hours there was significantly less phagocytosis by
human macrophages and no difference in phagocy-
tosis by murine peritoneal-derived macrophages
when compared with N IgG-treated controls. In con-
clusion, ANCAs accelerate apoptosis and secondary
necrosis in TNF-primed neutrophils by a mechanism
dependent on the generation of reactive oxygen spe-
cies, with uncoupling of nuclear and surface mem-
brane changes, resulting in a “reduced window of
opportunity” for phagocytic recognition and engulf-
ment before disintegration. (Am J Pathol 2000,
157:211–220)
The elimination of unwanted cells is regarded as an es-
sential component of many normal biological program,
including the resolution of inflammation. Programmed cell
death, or apoptosis, is a well-recognized process that is
accompanied by characteristic phenomena: cell shrink-
age, chromatin condensation, DNA fragmentation, mem-
brane blebbing, and finally, in some cell types, fragmen-
tation into membrane-bound apoptotic bodies.1 During
the apoptotic process, the plasma membrane of apopto-
tic polymorphonuclear leukocytes (PMNs) remains intact,
thus preventing release of histiotoxic contents from these
cells, which could provoke inflammation and tissue dam-
age. In human PMNs, apoptosis is associated with an
impairment of functional activity, including degranulation,
respiratory burst, and phagocytosis.2
There is strong evidence that PMNs migrating to in-
flamed sites are constitutively deleted by apoptosis, lead-
ing to safe phagocytic clearance of the intact dying cell,
with resolution of inflammation. The major clearance route
is via macrophages (mf), which have matured from
monocytes that lack phagocytic activity. Recognition of
apoptotic cells is achieved by displaying surface mem-
brane signals on the apoptotic cell surface. These include
phosphatidylserine (PS), a membrane phospholipid usually
present on the inner aspect of the membrane. Loss of
membrane phospholipid asymmetry and early external ex-
pression of PS have been documented as an early
marker of apoptosis on many cell types.3 Recognition of
these signals by mf occurs by uncharacterized but
stereospecific receptors for phosphatidylserine. Among
other recognition mechanisms, mf can deploy surface
avb3 vitronectin receptor integrin in cooperation with
CD36 and thrombospondin, which bridges the mf to
uncharacterized sites on the apoptotic PMN.4 Phagocy-
tosis of apoptotic cells has been documented in vivo in
experimental and clinical disease states, supporting the
importance of this process in the resolution of inflamma-
tion.5,6 The ingestion of apoptotic leukocytes by phago-
cytes, unlike the uptake of other biological material, fails
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to elicit a secretory or proinflammatory response.7 Some
investigators have even detected an immunosuppressive
effect of apoptotic leukocyte uptake by mf,3,8 which may
be important in the successful resolution of inflammation.
In contrast, apoptotic cells that fail to be cleared progress
to secondary necrosis, with removal of the resulting cell
fragments by phagocytes triggering the release of proin-
flammatory cytokines.9
It has previously been suggested that failure of the
apoptotic process and/or perturbation of clearance of
apoptotic PMNs can lead to secondary necrosis in situ,
and thence release of toxic leukocyte contents may result
in tissue injury and perpetuate the inflammatory re-
sponse.10 Such events may be of critical importance in
systemic vasculitis. Pathologically, anti-neutrophil cyto-
plasmic antibody (ANCA)-associated vasculitis is char-
acterized by a leukocytoclastic picture as shown by light
microscopy, and electron microscopy studies provide
evidence of leukocytes with apparently degraded nu-
clear material undergoing disintegration in tissues.11 This
is of interest, as Hebert and colleagues have demon-
strated that as PMN apoptosis progresses, cell morphol-
ogy changes from an early to a late picture with nuclear
evanescence12; eventually there is disintegration by sec-
ondary necrosis, a highly inflammatory event. Donald
speculated that the intravascular cell lysis documented in
his study of vasculitic lesions was due to a circulating
cytophilic antibody.11 We were interested in the possibil-
ity that this was due to disruption of the constitutive
apoptotic process of PMNs by ANCAs, autoantibodies
present in the sera of patients with Wegener’s granulo-
matosis and microscopic polyangiitis.13–15 The two major
antigens recognized by ANCAs are serine proteinase 3
(PR3-ANCA or cANCA), which is found predominantly in
Wegener’s granulomatosis, and myeloperoxidase (MPO-
ANCA or pANCA), which occurs in 70% of patients with
microscopic polyangiitis.16
In vitro studies have shown that ANCAs can activate
tumor necrosis factor-a (TNF-a)-primed PMNs and mono-
nuclear phagocytes to undergo a respiratory burst with
the release of reactive oxygen species as well as degran-
ulation of azurophil granules and secretion of proinflam-
matory cytokines.17,18 We hypothesized that PMNs incu-
bated with ANCAs would exhibit dysregulation of the
apoptotic process. In this study we report ANCA-PMN
coculture experiments in which TNF-a-primed PMNs
aged for 12 hours showed morphological evidence of
accelerated apoptosis that was dependent on the gen-
eration of reactive oxygen species. PMNs undergoing
accelerated apoptosis failed to exhibit coordinated ex-
pression of PS on the cell surface as assessed by an-
nexin V binding, suggesting dysregulated apoptosis. Fur-
thermore, human monocyte-derived mf showed reduced
phagocytosis of apoptotic TNF-a-primed PMNs cultured
with ANCAs for 12 hours. These data suggest a novel
mechanism for tissue injury in systemic vasculitis
whereby ANCA-activated primed PMNs undergo accel-
erated apoptosis. The potential for progression to dele-
terious secondary necrosis is promoted by dysregulation
of apoptosis such that there is a reduced window of
opportunity for safe clearance by macrophages.
Materials and Methods
Isolation of Human PMNs and Culture
Human PMNs were isolated as previously reported.19
Briefly, freshly isolated blood from six healthy donors was
mixed with acid citrate dextrose (ACD) in a ratio of 1:10.
This was then mixed with an equal volume of 4:5 Hespan
(6% Hetastarch in 0.9% sodium chloride) and with 1:5
diluted ACD (diluted with distilled water to 1:10). After
centrifugation (20 3 g, 15 minutes) the supernatant was
removed and centrifuged (160 3 g, 7 minutes). The re-
sulting supernatant was removed and discarded and the
cell pellet resuspended in 55% Percoll (Pharmacia, Upp-
sala, Sweden).
Discontinuous Percoll gradients were prepared. Nine
volumes of Percoll was mixed with one volume of 1.5
mol/L sodium chloride. This was then diluted with phos-
phate-buffered saline (PBS) to concentrations of 81%,
70%, and 55%. Three milliliters of 70% was layered onto
4.5 ml of 81%. Finally, the cell pellet, which was sus-
pended in 3 ml of 55% Percoll, was layered onto the
gradients. The band between 81% and 70% was har-
vested and washed (1200 rpm, 7 minutes). This gave a
cell purity of 95% neutrophils with 98% viability, as as-
sessed by trypan blue exclusion. Human monocytes
were prepared by retrieving cells at the 70% and 55%
interface. These were then washed with PBS and resus-
pended to 5 3 106cells/ml. One milliliter was added to
each well of a 24-well plate (Falcon) and incubated for 1
hour in serum-free Iscove’s Dulbecco’s minimum essen-
tial medium (DMEM). Cells were washed with ice-cold
saline to remove nonadherent cells and cultured for 4
days in Iscove’s DMEM with added 1% penicillin and
streptomycin and 10% autologous serum to mature into
mf (.90% pure).
PMN Incubation
Isolated PMNs were incubated in Iscove’s DMEM (Sig-
ma-Aldrich Company, Dorset, UK) with added antibiotics
and supplemented with 10% autologous platelet-poor
plasma-derived serum in a humidified atmosphere at
37°C with 4% added CO2. PMNs were cultured in Teflon
wells at a concentration of 2 3 106 cells/ml. Polymyxin
(Sigma) (10 mg/ml) was added to each well, except those
with added lipopolysaccharide (LPS), to counteract pos-
sible contamination of reagents with endotoxin. Limulus
assay showed endotoxin contamination of IgG (,0.06
EU/ml); other reagents were from endotoxin-free accred-
ited sources. Cells were cultured for 36 hours and sam-
pled at various time points. Quiescent PMNs or PMNs
primed with TNF-a (2 ng/ml) (NISBC, Potters Bar, UK)
were incubated with N IgG or ANCA IgG (either PR3-
ANCA or MPO-ANCA) at a concentration of 200 mg/ml.
Higher concentrations of IgG produced PMN clumping
(data not shown). In some experiments, catalase (5000
U/ml) was added before priming of PMN and the addition
of IgG.
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Isolation and Culture of Murine mf
Peritoneal mf were elicited into the peritoneal cavity of
12–16-week-old BALB/c mice with 3% thioglycollate me-
dium (Difco, Detroit, MI). Peritoneal exudate mf were
harvested 4 days later and cultured in 96-well plates
overnight in Dulbecco’s DMEM with 10% fetal calf serum
before use in the phagocytosis assay as previously de-
scribed.20
IgG Isolation
Serum was collected from patients with vasculitis who
fulfilled the Chapel Hill Consensus Conference definitions
for Wegener’s granulomatosis or microscopic polyangi-
itis21 and patients with antiglomerular basement mem-
brane disease. IgG was prepared from patient and nor-
mal human donor sera, using a Hi-trap protein G affinity
column (Pharmacia) as previously described.19 All IgG
samples were used individually. ANCA specificity was
confirmed by Western blot analysis and enzyme-linked
immunosorbent assay (data not shown). 4 MPO-ANCA
and 4-PR3 ANCA were isolated, and all ANCAs had a
serum titer greater than 1:400 by immunofluorescence.
Assessment of Apoptosis
Fluorescence Microscopy
Cells were sampled at the appropriate times, and the
fluorescence staining protocol was used as described
previously, with modifications.22 Briefly, the collected
cells were washed in PBS and resuspended at a density
of 1 3 106 cells/0.5 ml. To this, 20 ml of a 1:1 mixture of
ethidium bromide (100 mg/ml; Sigma) and acridine or-
ange (100 mg/ml; Sigma) was added. The cell suspen-
sion was incubated in the dark at room temperature for 5
minutes. The stained cells were then centrifuged at 1200
rpm for 5 minutes and resuspended in 20 ml of 10%
glycerol. The cell suspension was mounted on a slide
and viewed with a fluorescence microscope. At least 500
cells per slide were counted. Normal cell morphology
was defined as normal cells appearing large with multi-
lobed yellow-stained nuclei. Apoptotic morphology was
observed as yellow fluorescence staining of shrunken
nuclei. Cellular ghosts that stain dark green represent
late apoptotic PMNs (Figure 1).
Flow Cytometric Analysis of Immunofluorescent
Stained Cells
Flow cytometry of PMN binding fluorescein isothiocya-
nate (FITC)-conjugated annexin V (Sigma) was per-
formed as previously described.23 Isolated PMNs were
incubated with saturating amounts of FITC-conjugated
annexin V for 10 minutes on ice. Annexin-V-FITC conju-
gate (Sigma) was diluted by 1:3000 in Hanks’ balanced
salt solution with calcium and magnesium. One hundred
microliters of PMN mix was added to 400 ml of buffer
solution. Trypan blue staining was used to identify dead
cells. PMNs were analyzed by fluorescence-activated
cell sorter (FACS) within 30 minutes of labeling.
After labeling, PMNs were enumerated in a flow cytom-
eter (Becton Dickinson FACS 440) equipped with an
argon laser (wavelength 488 nm). Appropriate settings of
forward and side scatter were used to examine PMNs.
Cell debris was excluded from analysis by appropriately
raising the forward scatter threshold. More than 10,000
cells were examined at each experiment.
Gel Electrophoresis and DNA Fragmentation
DNA fragmentation in cultured cells by phenol:chloro-
form protein extraction was assessed by electrophoresis
through agarose gels as previously described.24
Assessment of PMN Activation
Production of Superoxide after Stimulation by ANCAs
Superoxide anion production was determined by the
superoxide dismutase (SOD) (Sigma) inhibitable reduc-
tion of ferricytochrome c (Sigma), as previously de-
scribed, with modifications.25 Fifty microliters of PMN
culture medium was added to a reaction mixture contain-
ing ferricytochrome c (75 mM) with or without SOD (150
U). The difference in reduction of ferricytochrome c in the
presence and absence of SOD, as determined spectro-
photometrically at 550 nM, was measured and calculated
using a molar extinction coefficient of 21.1 3 1023 M for
ferricytochrome c and a light path of 0.6 cm for a final
volume of 250 ml. Replicates were carried out at least in
quadruplicate.
Myeloperoxidase Release
PMNs primed with TNF-a, as described above, were
cultured with IgG for 90 minutes, and supernatants were
isolated by centrifugation at 13,000 rpm for 5 minutes
and assayed in triplicate for myeloperoxidase (MPO)
production. Ninety-six-well flat-bottomed plates (Bec-
ton-Dickinson, Oxford, UK) were used. To each well
50 ml of supernatant was added. Myeloperoxidase
(Calbiochem-Novabiochem (UK), Nottingham, UK)
was used at concentrations of 79 –2500 pg/ml, diluted
in Iscove’s DMEM, to produce a standard curve. To this
was added 200 ml of substrate solution containing 50
mmol/L K3PO4 at pH 6.0, 0.5% hexadecyl trimethyl am-
monium bromide (Sigma), 1 mg/ml O-diansidine dihydro-
chloride (Sigma), and 0.01% H2O2. Supernatants were
incubated in the dark for 2 minutes, and then the absor-
bance was measured at 492 nm with a Multiskan bichro-
matic analyzer.
Mf Interaction Assay
A well-established, microscopically quantified phago-
cytic assay of mf ingestion of apoptotic PMNs was used
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Figure 1. Fluorescence microscopy of aging PMNs, which were stained with a mixture of ethidium bromide and acridine orange. Original magnification, 3100.
Top: Freshly isolated cells (A) appear large with multilobed nuclei, staining orange. Bottom: Early apoptotic morphology is observed as yellow staining of
shrunken nuclei (B), whereas late apoptotic morphology was seen as cellular ghosts staining dark green with an absence of nuclear material (C).
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as previously described.26–29 Briefly, PMNs aged for 12
hours were washed once in Hanks’ balanced salt solu-
tion, suspended in Iscove’s DMEM without serum (con-
centration 5 3 106cells/ml). Cells (5 3 106) were added
to each well of human mf in a 24-well plate, and or 2.5 3
105 cells (50 ml) were added to murine peritoneal mf in
96-well plates. Plates were incubated at 37°C for 30
minutes in 4% CO2. The plates were washed with ice-
cold saline to remove noningested PMNs. The plates
containing the human mf layer were fixed in 2% glutar-
aldehyde for 2 minutes and stained for MPO. Using 403
phase-contrast light microscopy, we counted the portion
of human mf ingesting PMNs. Experiments were per-
formed in triplicate, and 100 mf were counted per well.
The phagocytic index was calculated as the percentage
of phagocytosing mf multiplied by the average number
of PMNs ingested per mf. The mf themselves were
routinely negative for peroxidase staining. For murine
peritoneal mf, after a 30-minute interaction, murine mf
were then trypsinized, and a separate cytocentrifuge
preparation was prepared for each well as previously
described.29,30 These were fixed with 2% glutaraldehyde
and stained for MPO and finally counterstained with He-
malum (BDH, Poole, UK). The proportion of murine mf
containing brown-staining MPO-positive PMNs was then
counted.
Statistical Analysis
Data are presented as the mean 6 SEM. Statistical sig-
nificance was determined using ANOVA for multiple com-
parisons; the Bonferroni test for pairs was used to com-
pare groups.
Results
ANCAs Do Not Affect Constitutive Apoptosis in
Unprimed PMNs
PMNs that were not deliberately primed in culture
showed a time-dependent increase in the percentage of
apoptotic cells, as assessed by morphology and binding
of FITC-conjugated annexin V (results not shown). When
these cells were cultured with ANCAs they showed no
difference in the percentage of cells judged to be apo-
ptotic by either technique at any time point (from 6 to 36
hours) compared with those PMNs incubated with N IgG
(results not shown). LPS was used to confirm that PMN
apoptosis could be delayed as previously shown.31
PMNs cultured with added LPS showed significant inhi-
bition of apoptosis at 18 hours (61.44% 6 11 normal
morphology and at 24 hours with 40% 6 17.911 normal
morphology) compared with cells cultured with N IgG (18
hours 28.64% 6 17.6 11 normal morphology and 24
hours 17.83% 6 15.7 11 normal morphology), P , 0.05;
all data quoted refer to assay of apoptosis by morphology
and are the results of four different neutrophil donors.
In TNF-a Primed PMNs, ANCAs Accelerate
Apoptosis, as Assessed by Morphology and
Internucleasomal Cleavage of DNA but Not by
Externalization of Phosphatidylserine
Activation of PMNs by ANCAs typically requires TNF-a
priming because this increases the surface expression of
PR3 and MPO,32,33 so that Fc receptors are cross-linked
by antibody.34 These observations prompted us to prime
freshly isolated PMNs with TNF-a (2ng/ml) before the
addition of ANCAs or N IgG. TNF-a accelerates PMN
apoptosis at early time points up to 6 hours and delays
apoptosis at later times.31,35 In preliminary experiments,
TNF-a addition to incubated PMN without added IgG
resulted, as expected,31,35 in an initial increase in the
percentage of apoptotic PMN at 6 hours, which was
followed by a decrease in apoptosis at later time points
compared with unprimed PMNs, as assessed by mor-
phology (t 5 6 hours TNF-primed PMN 19.4 6 2.7%
apoptotic cells, unprimed PMN 11.2 6 2.3% apoptotic
cells, P , 0.05; t 5 18 hours TNF-primed PMN 46.9 6
2.68% apoptotic cells, unprimed PMN 57.98 6 3.29%
apoptotic cells, P , 0.05; N 5 3). The correlation coeffi-
cient between annexin V binding and morphology was
r 2 5 0.88 with P , 0.001.
The effects of ANCAs on apoptosis in primed PMNs
was assessed by 1) morphology using immunofluores-
cence microscopy and dual staining of TNF-a-primed
PMN with ethidium bromide and acridine orange, 2) ex-
ternalization of PS as assessed by binding of FITC-con-
jugated annexin V, and 3) internucleosomal cleavage of
DNA demonstrated by gel electrophoresis. Externaliza-
tion of PS is considered to be an early feature of apopto-
sis induced by many different stimuli and, in PMN under-
going apoptosis, is tightly linked to nuclear changes.36
Figure 2. Fluorescence microscopy of primed PMNs that were cultured with
TNF only, normal IgG, or ANCA (either anti-MPO or anti-PR3) (200 mg/ml)
and stained with a mixture of ethidium bromide and acridine orange. There
were accelerated changes of early apoptosis in those cells incubated with
ANCA at 12 hours (A) and changes in late apoptosis at 18, 24, and 36 hours
compared with normal IgG (*P , 0.05) (B). Data are expressed as a per-
centage of the total number of cells that showed apoptosis. Data are means 6
SD of six experiments.
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TNF-a-primed PMNs were incubated for up to 36 hours
and assayed at various time points. At 12 hours primed
PMNs incubated with ANCAs showed accelerated mor-
phological changes of early apoptosis compared with
controls, with ANCA-treated cells showing an increased
population with typical nuclear chromatin condensation.
Furthermore, in keeping with an acceleration of the con-
stitutive processes of PMN apoptosis, by 18 and 24 hours
a greater proportion of ANCA-treated cells exhibited typ-
ical nuclear evanescence of late apoptosis compared
with cells incubated with N IgG (Figure 2). There were no
significant differences between PR3-ANCA and MPO-
ANCA. Indeed, as one would expect with accelerated
apoptosis, there were significantly more cells staining
positive for trypan blue at all time points when primed
PMNs were incubated with ANCAs compared with those
cells incubated with N IgG (Figure 3).
Further experiments using a disease control antibody
were performed to ensure that the accelerated apoptosis
with TNF-a-primed PMNs was specific to ANCAs. There
was no difference in the rate of apoptosis in those primed
cells treated with N IgG or anti-glomerular basement
membrane (GBM) antibody (t 5 18 hours N IgG 40.7 6
3.9%, anti-GBM 45.9 6 4.4% apoptotic cells; t 5 24 hours
N IgG 55.22 6 4.2%, anti-GBM 63.1 6 4.4% apoptotic
cells, P . 0.05).
However, TNF-a-primed PMNs incubated with ANCAs
showed no significant difference in the percentage of
apoptotic PMNs binding annexin V compared with N IgG,
despite the morphological evidence of accelerated apo-
ptosis (Figure 4). To extend these studies, we investi-
gated whether the treatment of primed PMNs with ANCAs
had interfered with DNA fragmentation, which occurs late
in apoptosis. Cells undergoing apoptosis usually exhibit
DNA fragmentation in a characteristic internucleosomal
“ladder” pattern. This represents endogenous endonu-
clease activation, the amount of DNA in each fragment
being a multiple of 180–200 bp. Both ANCA- and N
IgG-cultured PMNs showed the characteristic DNA lad-
dering pattern, thereby corroborating the morphological
findings despite the failure to accelerate externalization
of PS. Thus externalization of PS can also be dissociated
from DNA fragmentation (Figure 5).
These data demonstrated that in PMNs deliberately
primed with TNF-a there was dysregulation of the apo-
ptotic process with uncoupling of plasma membrane
changes from nuclear changes, with the result that there
was accelerated development of the late apoptotic state
and progression to secondary necrosis, but without ac-
celeration of surface changes that lead to safe recogni-
tion by phagocytes.
Dysregulated Apoptosis Results in Uncoupling
from Safe Phagocytosis
We proceeded to investigate the possibility that uncou-
pling of plasma membrane changes from nuclear
changes would result in failure of mf recognition by
macrophage interaction assays. TNF-a primed PMN in-
cubated with ANCA or N IgG were cultured for 12 hours.
Primed PMN were then coincubated with human mono-
cyte-derived mf, and phagocytosis was assayed. By
morphological assessment of PMN apoptosis, primed
PMNs incubated with ANCAs showed significantly more
apoptosis at 12 hours than those cells incubated with
normal IgG (Figure 6A). However, despite the increased
proportion of PMNs exhibiting morphological evidence of
Figure 3. Cell viability was assessed by trypan blue staining. TNF-primed
PMNs alone or TNF-primed PMNs incubated with normal IgG or ANCA
(either anti-MPO or anti-PR3) (*P , 0.05) were assessed for cell viability at
various time points. Data are expressed as a percentage of the total number
of cells. Data are means 6 SD of six experiments.
Figure 4. Coculture of TNF-a primed PMN with TNF only, normal IgG, or
ANCA (either anti-MPO or anti-PR3) (200 mg/ml). Primed PMNs incubated
with ANCA showed no increase in phosphatidylserine externalization, as
assessed by FACS analysis of binding of FITC-conjugated annexin V (*P ,
0.05). Data are expressed as a percentage of the total number of cells that
showed apoptosis. Data are means 6 SD of six experiments.
Figure 5. DNA fragmentation of PMNs cultured for 18 hours. Lane 1: mark-
ers; lane 2: unprimed neutrophils alone; lane 3: primed PMNs incubated
with MPO-ANCA; lane 4: primed PMNs incubated with N IgG; lane 5:
primed PMNs incubated with PR3-ANCA; lane 6: primed PMNs alone.
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apoptosis, phagocyte uptake for those cells incubated
with ANCAs was significantly less than for those cells
cultured with N IgG (Figure 6B).
Murine peritoneal-derived mf phagocytose apoptotic
cells via a recognition mechanism dependent on expo-
sure of PS on the target cell.36–38 To assess whether
uncoupling of phagocytosis from morphological changes
of apoptosis was directly related to failure of ANCA to
accelerate the expression of PS, we used murine perito-
neal derived mf in interaction assays. Despite increased
apoptosis as assessed by morphology (Figure 7A), there
was no significant difference in the phagocytosis of ap-
optotic PMNs by murine peritoneal-derived mf in cells
incubated with ANCAs compared with cells incubated
with N IgG (Figure 7B). This suggested that murine peri-
toneal-derived mf failed to recognize a population of
apoptotic cells because of delayed phosphatidylserine
externalization. These studies add weight to our findings
that ANCA-accelerated apoptosis is dysregulated with
uncoupling of surface membrane changes and nuclear
and cytoplasmic changes of apoptosis.
ANCA-Mediated Dysregulation of PMN
Apoptosis Depends on Generation of a
Respiratory Burst
Primed PMNs activated by ANCAs undergo a respiratory
burst with the release of oxygen products,17,18 degranu-
late, and secrete proinflammatory cytokines. Reactive
oxygen species have been implicated as an important
stimulus to apoptosis.39–43 As far as we are aware, there
have been no previous reports regarding dysregulated
apoptosis induced by PMN activation and generation of
reactive oxygen species. To investigate further the mech-
anism of ANCA-dysregulated apoptosis in PMNs, we ex-
amined the possible role of superoxide anion production.
Figure 6. Primed neutrophils were aged in culture for 12 hours with N IgG
or ANCA, and apoptosis was assessed by morphology and expressed as a
percentage of the total number of cells that showed apoptosis (A). Macro-
phage interaction experiments were performed using human monocyte-
derived macrophages and data expressed by the phagocytic index (B). Data
are means 6 SD of eight experiments. There were significantly more apo-
ptotic cells when they were incubated with ANCA than when they were
incubated with normal IgG (A). However, significantly fewer of those cells
incubated with ANCA were phagocytosed compared with those cells incu-
bated with normal IgG (B) (*P , 0.05).
Figure 7. Primed neutrophils aged in culture for 12 hours with N IgG or
ANCA. Apoptosis was assessed by morphology and expressed as a percent-
age of the total number of cells that were apoptotic (A). Macrophage
interaction experiments were performed using murine peritoneal-derived
macrophages, and data were expressed by the phagocytic index (B). Data
are means 6 SD of three experiments. There were significantly more apo-
ptotic cells when they were incubated with ANCA than when they were
incubated with normal IgG (A). However, there was no difference in the
number of cells phagocytosed when they were incubated with ANCA or
normal IgG (B) (*P , 0.05).
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We cultured TNF-a-primed PMNs from normal donors
and from patients with chronic granulomatous disease
(CGD). PMNs from patients with CGD are unable to gen-
erate a respiratory burst, although they do degranulate
with the release of MPO.44 TNF-a-primed PMNs cultured
with ANCAs showed increased production of superoxide
at 100 minutes (PR3-ANCA 11.16 6 0.86 nmol/L/105 cells
and MPO-ANCA 12.849 6 0.81 nmol/L/105 cells) com-
pared with those cells incubated with N IgG (8.04 6 0.89
nmol/L/105 cells, P , 0.01). This was also true at 4 hours
(PR3-ANCA 4.660 6 0.97 nmol/L/105 cells, MPO-ANCA
3.74 6 1.99 nmol/L/105 cells, and normal IgG 1.01 6 0.70
nmol/L/105 cells, P , 0.05). By 8 hours the production of
superoxide had decreased to negligible levels (Table 1).
TNF-a-primed PMNs isolated from patients with CGD
showed no difference in PMN apoptosis between cells
incubated with ANCA or N IgG (Figure 8). As expected,
PMNs isolated from patients with CGD did not undergo a
respiratory burst after stimulation with ANCA, although
there was activation with the release of MPO (normal
PMNs treated with ANCA 426 6 37.1 pg/ml, N IgG
treated 117 6 29.3 pg/ml, P , 0.01; CGD PMNs treated
with ANCA 572 6 48.5 pg/ml, N IgG 98 treated 6 39.8
pg/ml, P , 0.01).
Catalase, an antioxidant that catalyzes the reaction of
hydrogen peroxide producing H2O and O2 was added to
PMNs form healthy donors before TNF priming and the
addition of ANCAs. There was inhibition of the acceler-
ated apoptosis induced by ANCAs (t 5 18 hours PR3-
ANCA without catalase 85 6 4% apoptotic cells; PR3-
ANCA with catalase 46 6 3.5% apoptotic cells, P , 0.01;
MPO-ANCA without catalase 87 6 5% apoptotic cells,
MPO-ANCA with catalase 56 6 6% apoptotic cells, P ,
0.05). These experiments indicated that in vitro, dysregu-
lation in PMN apoptosis induced by ANCA was critically
related to the production of reactive oxygen species.
Discussion
Apoptosis is a physiological form of programmed cell
death that is responsible for the deletion of unwanted
cells and is essential for the resolution of inflammation.
This is the first study to identify an effect of ANCA on
TNF-a-primed PMN apoptosis whereby ANCAs acceler-
ate constitutive PMN death by a mechanism dependent
on NADPH oxidase and generation of reactive oxygen
species. The normal processes of constitutive PMN death
in which nuclear changes, cell surface PS exposure, and
recognition by macrophages are all closely linked are
dysregulated by ANCA. ANCA accelerates the apoptosis
of TNF-a-primed PMNs with uncoupling of nuclear and
cytoplasmic changes of apoptosis from the plasma mem-
brane changes, when compared with N IgG. This is man-
ifested by the acceleration of sequential morphological
stages of apoptosis12 and DNA fragmentation, without
associated acceleration of the externalization of PS.
A key finding of this study was that autoantibodies to
PMN components, which are believed to play important
roles in the pathogenesis of autoimmune vasculitis, dys-
regulate PMN apoptosis in a manner that is likely to
promote tissue injury at inflamed sites. First, exposure of
primed PMNs to ANCA accelerates the progression of
constitutive PMN death through apoptosis to secondary
necrosis, in which uncontrolled release of injurious PMN
contents is inevitable. Because monocytes emigrating
into tissues must mature into mf before they become
capable of clearing apoptotic PMN, acceleration of PMN
death threatens the synchronicity of monocyte maturation
and PMN apoptosis, with undesirable secondary necro-
sis of PMNs. Second, this threat of PMN disintegration is
compounded by ANCA-mediated dysregulation of apo-
ptosis, which results in the acceleration of PMN death
without accelerated surface membrane signals such as
PS that allow recognition by mf. Thus there is a short-
ened time interval during which intact ANCA-activated
PMNs are available for phagocyte clearance. Extrapola-
tion of these data to the PMN fate in ANCA-associated
Table 1. Production of O2
2 (nmol/105 cells)
t 5 100 minutes t 5 4 hours t 5 8 hours t 5 12 hours
Normal IgG 6 SEM 8.04 1.01 0.000 0.000
0.89 0.70 1.202 0.181
PR3-ANCA 6 SEM 11.16 4.66 0.061 0.816
0.86 0.697 0.840 0.197
MPO-ANCA 6 SEM 12.85 3.74 0.000 0.606
0.81 1.441 0.505 0.849
Statistics * *
MPO, myeloperoxidase.
*P , 0.05 when compared with those primed cells incubated with normal IgG.
The data are means of six experiments, all performed in at least quadruplicate 6 SEM.
Figure 8. PMNs isolated from patients with chronic granulomatous disease
were primed with TNF and cultured alone or with normal IgG or ANCA
(anti-MPO or anti-PR3). Apoptosis was assessed by morphology, viewed by
fluorescent microscopy, and stained with ethidium bromide and acridine
orange. Apoptosis was delayed as expected, and there was no difference
between those cells that were primed with TNF and incubated with ANCA
compared with TNF-primed PMNs incubated with normal IgG (*P , 0.05).
Data are expressed as a percentage of the total number of cells that showed
apoptosis. Data are means 6 SD of three experiments.
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vasculitis requires considerable caution. Nevertheless,
we submit that ANCA-mediated dysregulation of PMN
apoptosis and clearance by phagocytes is a hitherto
unrecognized mechanism for leukocytoclasis in vascu-
litic lesions, the highly characteristic histological picture
of PMN disintegration seen in ANCA-associated disor-
ders.11
There are reported precedents for the uncoupling of
nuclear and membrane changes of apoptosis that we
have observed in our studies. In a system using the
mitochondrial inhibitors antimycin A and oligomycin,
Zhuang et al reported dissociation of cell membrane
changes from other features of apoptosis in PMNs asso-
ciated with failure of phagocyte recognition.45 We have
now found that a naturally occurring autoantibody may
have functional effects similar to those of these mitochon-
drial inhibitors.
Our data clearly demonstrate that ANCAs dysregulate
the constitutive programmed cell death of TNF-a-primed
PMNs in a manner that is dependent on the generation of
reactive oxygen species. When we used cells isolated
from patients with CGD, there was no acceleration in
apoptosis when TNF-a-primed PMNs were incubated
with ANCA, despite activation shown by the production of
MPO. PMNs from these patients are unable to produce
free oxygen radicals because of a defect in one of the
components of the NADPH oxidase.46,47 As a result there
is a significant delay in the rate at which these PMNs
undergo apoptosis, which can be reversed by the addi-
tion of hydrogen peroxide.41 Other studies have also
shown that the production of reactive oxygen species
with the activation of PMNs accelerates PMN apopto-
sis39–41,43,48,49. This is exemplified by the accelerated
apoptosis seen after Fcg receptor-mediated phagocyto-
sis of opsonized particles, which is dependent on the
generation of intracellular reactive oxygen species.39,49
Previous studies within our laboratory have suggested
that ANCA activation of primed neutrophils generating a
respiratory burst is dependent on Fcg receptor liga-
tion.34,50 In our studies the addition of catalase to culture
media inhibited the accelerated apoptosis of TNF-primed
PMNs by ANCA. This provided further evidence of the
importance of reactive oxygen intermediaries in the dys-
regulation of apoptosis of TNF-primed PMNs by ANCA.
The accelerated dysregulated apoptosis induced by
ANCA was dependent on priming of PMNs by TNF-a;
PMNs incubated with ANCA that were not deliberately
primed showed no accelerated apoptosis at any time
points up to 36 hours. As PMNs become apoptotic there
is an increased expression of PR3 and MPO on the PMN
surface; binding of these antigens by ANCA has been
suggested as a possible mechanism for PMN activation
without the requirement for TNF priming.51 However, we
found this to be unlikely, as stimulating PMNs with ANCA
showed a time-dependent decrease in superoxide gen-
eration as PMNs aged (manuscript submitted), as previ-
ously described with fMLP.2
In conclusion, we have shown for the first time that
TNF-a-primed PMNs incubated with ANCA result in PMN
activation, with the generation of reactive oxygen species
and acceleration of apoptosis and secondary necrosis.
Further studies are required to identify the aberrant path-
ways dissociating surface changes from other features of
apoptosis induced by ANCA. This could reveal important
targets for therapeutic manipulation.
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